Human Immunodeficiency Virus Therapeutics Market by Drug Class (Nucleoside Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Inhibitors, Entry & Fusion Inhibitors), Therapy Type (Antiretroviral Therapy, Pre-Exposure Prophylaxis, Post-Exposure Prophylaxis, Long-acting Injectable Therapies), Drug Type (Branded Drugs, Generic Drugs), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Analysis, 2026-2033